登录新浪财经APP 搜索【信披】查看更多考评等级 （一）会议召开情况 证券代码：301366 证券简称：一博科技 公告编号：2025-043 深圳市一博科技股份有限公司 2025年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1、本次股东会无增加、变更、否决议案的情况； 2、本次股东会不涉及变更以往股东会通过的决议。 一、会议召开和出席情况 1、会议召开时间： （1）现场会议时间：2025年10月10日（星期五）下午14：30 （2）网络投票时间：2025年10月10日，其中，通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025年10月10日上午9:15-9:25、9:30-11:30，下午13:00-15:00；通过深圳证券交易所互联网投票系 统投票的具体时间为：2025年10月10日9:15-15:00。 2、会议召开地点：深圳市南山区粤海街道深大社区深南大道9819号地铁金融科技大厦11F公司会议室 3、会议召开及表决方式：本次股东会以现场会议形式召开，采用现场投票与网络投票相结合的方式表 决。 4、 ...

证券代码：688496 证券简称：清越科技 公告编号：2025-047 苏州清越光电科技股份有限公司 关于变更会计师事务所的公告 （一）机构信息 1、机构信息 名称：北京德皓国际会计师事务所（特殊普通合伙） ● 拟聘任的会计师事务所名称：北京德皓国际会计师事务所（特殊普通合伙）（以下简称"北京德皓国 际"） ● 原聘任的会计师事务所名称：立信会计师事务所（特殊普通合伙）（以下简称"立信"） ● 变更会计师事务所的简要原因及前任会计师的异议情况： 为充分保障公司审计工作安排，更好地适应公司未来业务发展，综合考虑市场信息，基于审慎性原则以 及公司对审计服务的需求，根据《国有企业、上市公司选聘会计师事务所管理办法》的相关规定，经履 行相应的选聘程序并根据评估结果，公司拟聘任北京德皓国际为公司2025年度财务报告审计机构以及内 部控制审计机构。公司已就本次变更会计师事务所事项与立信进行充分沟通，立信对本次变更事项无异 议。 ● 本事项尚需提交公司2025年第五次临时股东会审议。 一、拟聘任会计师事务所的基本情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确 ...

2025年9月12日，九江善水科技股份有限公司第三届董事会第十六次会议审议通过《关于使用部分超募 资金永久补充流动资金的议案》，该事项尚需股东会审议。2021年12月公司募资净额13.84亿元。此 前，2022 - 2024年已累计使用超募资金6354万元。截至2025年8月31日，剩余超募资金1017.22万元（含 利息）。此次公司拟用这笔资金永久补充流动资金，约占超募资金总额14.34%，用于主营业务生产经 营。公司承诺补流后12个月内不进行风险投资和财务资助，且每12个月累计补流不超超募资金总额 30%。 ...

Core Viewpoint - The company has approved the use of part of the raised funds to permanently supplement its working capital, which is expected to enhance the efficiency of fund utilization and reduce financial costs [10][15][16]. Group 1: Supervisory Board Meeting - The sixth meeting of the fourth supervisory board was held on September 5, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1][3]. - The supervisory board approved the proposal to use part of the raised funds, amounting to RMB 156 million, to permanently supplement working capital, which constitutes 29.87% of the total raised funds [10][12]. - The proposal will be submitted to the shareholders' meeting for approval [4][7]. Group 2: Fund Utilization - The company plans to use RMB 156 million of the raised funds for working capital, which will not affect the funding needs of investment projects and will not involve high-risk investments within the next 12 months [10][12]. - The total amount of raised funds was RMB 1,226.34 million, with a net amount of RMB 1,085.40 million after deducting related fees [10][11]. - The company has committed to not exceeding 30% of the total raised funds for working capital supplementation within any twelve-month period [12][13]. Group 3: Governance Changes - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors, which will also involve amendments to the company’s articles of association [40][41]. - The company plans to change its business scope by removing "first-class value-added telecommunications services" from its operations [40]. - The board of directors has proposed to increase the number of directors from 6 to 8, including the addition of one independent director and one employee representative director [18][19].

与会监事对本次会议议案进行了审议，形成决议如下： （一）审议通过《关于使用部分超募资金永久补充流动资金的议案》 经审议，监事会认为公司使用部分超募资金永久补充流动资金内容及审议程 序符合《上市公司募集资金监管规则》及修订说明、《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》以及《上海证券交易所科创板股票上 市规则》等相关法律法规的规定。公司本次使用部分超募资金永久补充流动资金 有助于满足公司流动资金需求，提高募集资金的使用效率，降低公司的财务成本， 不存在变相改变募集资金用途的行为，不影响募集资金投资项目正常实施，不存 在损害公司和全体股东利益的情况。 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）披露的 《关于使用部分超募资金永久补充流动资金的公告》（公告编号：2025-030）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 证券代码：688479 证券简称：友车科技 公告编号：2025-029 用友汽车信息科技（上海）股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依 ...

Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to discuss key proposals, including the use of excess raised funds to supplement working capital and the reappointment of an accounting firm for financial auditing [6][8]. Group 1: Meeting Procedures - The meeting will follow a structured agenda, allowing shareholders to exercise their rights, including speaking, questioning, and voting [2][3]. - Shareholders must register and present necessary identification documents to participate in the meeting [1][2]. - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][6]. Group 2: Proposals - Proposal 1 involves using CNY 72 million (approximately USD 10.1 million) of excess raised funds to permanently supplement working capital, which represents 29.73% of the total excess funds raised of CNY 242.2 million (approximately USD 34.1 million) [6][8]. - Proposal 2 seeks to reappoint Rongcheng Accounting Firm for the 2025 financial audit, with an audit fee of CNY 700,000 (approximately USD 98,000), maintaining the same fee as the previous year [8][12].

使用部分超募资金永久补充流动资金的核查意见 民生证券股份有限公司 关于深圳市曼恩斯特科技股份有限公司 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为深圳 市曼恩斯特科技股份有限公司（以下简称"曼恩斯特"或"公司"）首次公开发 行股票并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》 《上 市募集资金监管规则》《深圳证券交易所创业板股票上市规则》《深圳证券交易 所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关规定，对 曼恩斯特使用部分超募资金永久补充流动资金事项进行了核查，具体情况如下： 一、募集资金的基本情况 经中国证券监督管理委员会（以下简称"证监会"）《关于同意深圳市曼恩 斯特科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕363 号）同意注册，公司首次公开发行人民币普通股（A 股）股票 3,000.00 万股，每 股面值 1 元，每股发行价格为 76.80 元，募集资金总额为 230,400.00 万元。扣除 各项发行费用后，实际募集资金净额为 210,689.48 万元，其中超募资金 157,595.97 万元。大信会计师事务所（特殊普通 ...

Core Viewpoint - The company plans to permanently supplement its working capital with the remaining over-raised funds of RMB 5,072.57 thousand from its initial public offering (IPO) project, which requires approval from the shareholders' meeting [1][5][6] Fundraising Basic Situation - The company raised a total of RMB 119,000.00 thousand from the IPO by issuing 68 million shares at a price of RMB 17.50 per share, with a net amount of RMB 106,247.08 thousand after deducting issuance costs of RMB 12,752.92 thousand [1][2] Investment Project Situation - The net amount raised from the IPO was planned to be invested in specific projects, with a total investment amount of RMB 100,000.00 thousand [2] Use of Over-raised Funds - The company has used over-raised funds for share repurchase, with a total repurchase amount of RMB 138,809,738.95, of which RMB 70,135,413.12 was from over-raised funds [3][4] - As of June 30, 2025, the remaining over-raised funds amounted to RMB 5,072.57 thousand, primarily from interest income and cash management product returns [4][5] Remaining Over-raised Funds Usage Plan - The company plans to use RMB 5,072.57 thousand of the remaining over-raised funds to permanently supplement working capital, which is within the regulatory limits set by the China Securities Regulatory Commission and the Shanghai Stock Exchange [4][5][6] Related Explanation and Commitment - The company commits that the cumulative amount used to supplement working capital within 12 months will not exceed 30% of the total over-raised funds [5]

Fundraising Overview - The company raised a total of RMB 119 million from its initial public offering (IPO), with a net amount of RMB 106.25 million after deducting issuance costs of RMB 12.75 million [1] - The IPO involved the issuance of 68 million shares at a price of RMB 17.50 per share [1] Investment Project Status - The net amount raised is planned to be invested in specific projects totaling RMB 100 million, with adjustments made to the expected operational status dates for several projects [2] - The project "New Generation Laser Display Product R&D and Industrialization" is now expected to reach operational status by December 2022, while the "Headquarters R&D Center Project" and "Information System Upgrade Project" have been postponed to March 2025 [2] Use of Excess Funds - The company has approved the use of excess funds for share repurchase, with a total repurchase amount not less than RMB 10 million and not exceeding RMB 20 million, at a price not exceeding RMB 26.89 per share [3][4] - As of June 30, 2025, the total excess funds amount to RMB 70.14 million, with RMB 5.07 million planned for permanent working capital supplementation [5] Board and Supervisory Committee Approval - The board of directors approved the use of excess funds for permanent working capital on August 28, 2025, pending shareholder approval [6] - The supervisory committee also reviewed and agreed that the use of excess funds for working capital would enhance fund utilization efficiency without significantly impacting normal operations [6] Sponsor's Verification Opinion - The sponsor, Huatai United Securities, confirmed that the use of excess funds for permanent working capital complies with relevant regulations and does not harm the interests of shareholders, particularly minority shareholders [7][8]

Core Viewpoint - Yunnan Betaini Biotechnology Group Co., Ltd. plans to use part of its raised funds to temporarily supplement working capital, addressing a temporary cash flow gap due to market changes [1][2]. Fundraising and Usage - The company raised a total of 3,636 million shares at a price of 47.33 yuan per share, totaling 3,010 million yuan, with a net amount of 2,884 million yuan after deducting issuance costs [1]. - The total investment for projects funded by the raised capital is 1,535 million yuan, with excess funds amounting to 1,349 million yuan [1]. - Previous arrangements for the use of excess funds include: - 2021: 400 million yuan for permanent working capital [2]. - 2023: Up to 320 million yuan for temporary working capital, fully repaid by August 8, 2024 [2]. - 2024: 360 million yuan for the "Betaini Central Factory Phase II Project" [2]. - 2024: Up to 320 million yuan for temporary working capital, fully repaid by August 14, 2025 [2]. - 2025: Up to 700 million yuan of idle raised funds and 2,500 million yuan of idle self-owned funds for cash management [2]. - As of August 14, 2025, the balance of excess funds was 325 million yuan, with 340 million yuan allocated for cash management [2]. Board Approval and Compliance - The proposal to use up to 320 million yuan of excess funds for temporary working capital has been reviewed and approved by the audit committee and independent directors, confirming compliance with relevant regulations [3]. - The sponsoring institution, Guosen Securities Co., Ltd., has no objections to this matter [3].